340B Health

340B Insight Podcast

340B Insight

340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.

Listen and Subscribe

Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org

Follow 340B Health on Twitter, Facebook, and LinkedIn

 


Episodes

  • Episode 22: Ryan White Clinics and Their Importance to the 340B Community


    This week we are joined by Dr. John Carlo, CEO of Prism Health North Texas. Prism Health is a Ryan White Clinic, which are grantees of the Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS program. They provide care to patients at risk of or living with HIV/AIDS and are one of 16 types of 340B covered entities. John discusses 340B’s role in Prism Health’s ability to care for patients, how Ryan White Clinics work together with 340B hospitals, how they are serving patients during the pandemic, and the latest innovations in HIV care. Before the interview, we share important updates related to drug company denials of 340B discounts to covered entities that partner with community pharmacies. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode 21: Pursuing Health Equity: Part Two


    This week we continue our two-part series focused on how 340B hospitals are pursuing health equity. In our recently released Health Equity Report, 340B Health profiled nine hospitals working to eliminate health disparities in their communities. Today, we continue sharing the stories of three hospitals from that report. For this episode, we are broadcasting from our virtual booth in the exhibit hall at the 340B Coalition Winter Conference that started Feb. 16 and will run through Feb. 24.

    After we recorded this episode, a federal judge granted the government’s motion to dismiss a joint lawsuit that 340B Health and other plaintiffs had filed over drug company refusals to offer 340B pricing on drugs dispensed at community pharmacies. Read our statement about the decision, and we will provide additional analysis of the decision in upcoming episodes.

    We sit down this week with health equity leaders from each of the three hospitals: Rukiya Curvey Johnson, director of community health and engagement at Rush University System for Health in Chicago; Dr. Cheryl Clark, director of health equity, research and intervention at Brigham and Women’s Hospital’s Center for Community Health and Health Equity in Boston; and Greta Todd, executive director of diversity inclusion and community affairs at St. Louis Children’s Hospital. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode 20: Pursuing Health Equity


    This week, we begin a two-part series focused on how 340B hospitals are pursuing health equity. The COVID-19 pandemic has spotlighted the significant racial and ethnic disparities in health care and patient health outcomes. Today, we focus on three hospitals featured in 340B Health’s recently released health equity report and hear more about how they’re working to eliminate health disparities in their communities. Before we launch into the episode, we answer a member question about the many lawsuits that have been filed related to disputes over 340B contract pharmacies.

    We sit down with representatives from three hospitals: Dr. Cheryl Clark, director of health equity, research and intervention at Brigham and Women’s Hospital; Rukiya Curvey Johnson, director of community health and engagement at Rush University System for Health in Chicago; Julia Bassett, manager of health and community benefit at Rush; and Greta Todd, executive director of diversity inclusion and community affairs at St. Louis Children’s Hospital. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode 19: 340B Hospitals Are COVID Vaccine Leaders


    This week we are joined by Scott Milner, senior director of pharmacy, business development, purchasing, 340B, and infusion services at St. Luke’s Health System in Idaho. Scott shares his personal experiences on how the health system has been finding ways to overcome COVID-19 vaccine distribution challenges and describes how the effort has become a personal mission for him. Prior to the interview, we discuss in our news update segment how drug companies are suing HHS in response to the department’s advisory opinion on 340B contract pharmacies. When we recorded the episode, three companies had filed such lawsuits. Since then, a fourth company also has gone to court over the issue. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode 18: Preparing for HRSA Audits


    This week we are joined by Steven Miller, vice president of pharmacy services at 340B Health. Steve discusses Health Resources & Services Administration (HRSA) audits of 340B hospitals and shares practical advice for how hospitals can best prepare, including the resources that are available to them. Prior to the interview, we provide a major news update you might have missed during the holiday season on the ongoing 340B contract pharmacy issue. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode 17: Maureen Testoni Recaps 340B for 2020


    In our final episode of 2020, we are joined by Maureen Testoni, the president and CEO of 340B Health. Our episode follows up last week’s bonus episode on 340B Health’s recent joint lawsuit against the Department of Health and Human Services regarding drug manufacturers’ refusals to provide 340B discounts when drugs are dispensed at community-based contract pharmacies. Maureen provides additional analysis on the issue and discusses her concerns with how some drug companies are attempting to change 340B into a rebate program. She also discusses the role 340B has played in helping hospitals respond to the COVID-19 pandemic this year. (Transcript)

    Read more

    This Episode is Sponsored By